Joint ventures and collaborations have always been a prominent feature of the life sciences and technology industries. Since the Great Recession, strategics and financial firms have pursued them in new ways, including for creative funding, new product collaboration and staged acquisitions. In this webinar, we share with you 10 suggestions for creating successful joint ventures and collaborations in the current environment.
Panelist
David Zampa, Partner, Chicago
Sidley Austin’s Global Life Sciences Practice presents:
WHAT’S NEXT?
A series of presentations on emerging legal issues across the life sciences arena:
- “Winning at International Commercial Arbitration”: Lessons and best practices from the Life Science Industry
- Next Generation of In Vitro Diagnostics
- Regulation meets Competition – emerging trends in the US, EU and China
- Global Clinical Trials: Update on Regulatory Modernization in US, EU, and China
- Proliferation of Cost and Clinical Effectiveness in Drug and Biotech Pricing: HTAs, CER and VBP
